Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Alejandro D. Perez, PharmD
Advertisement
Articles by Alejandro D. Perez, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Community Pharmacy Must Pair Trust With Digital Convenience
5